FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20250416E00437
1. Date of relevant event: 11/04/2025
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 01877
4. Name of listed corporation: Shanghai Junshi Biosciences Co., Ltd. - H Shares 
5. Class of shares: A Shares 
6. Number of issued shares in class: 766,394,171
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Tang
(Other names) Yi
10. Name of director (Chinese): 湯毅 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1213The number of shares in which you are interested has reduced because:
any other event (you must briefly describe the relevant event in the Supplementary Information box)
 
2501Other (you must describe the capacity in the Supplementary Information box)
 
2501Other (you must describe the capacity in the Supplementary Information box)
 		 147,967,786         
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position203,926,28626.61
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position55,958,5007.30
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2101Beneficial owner
Long position7,774,500
2201Interest of corporation controlled by you
Long position48,184,000
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
深圳前海源本股权投资基金管理有限公司深圳市前海深港合作区前湾一路鲤鱼门街1号前海深港合作管理局综合办公楼A栋201室Tang Yi60.00N
Long position48,184,000
苏州本裕天源生物科技合伙企业(有限合伙)中国(江苏)自由贸易试验区苏州片区苏州工业园区葑亭大道668号11幢瑞奇大厦708室深圳前海源本股权投资基金管理有限公司86.28Y
Long position4,600,000
苏州瑞源盛本生物医药管理合伙企业(有限合伙)中国(江苏)自由贸易试验区苏州片区苏州工业园区葑亭大道668号11幢瑞奇大厦708室深圳前海源本股权投资基金管理有限公司39.52Y
Long position43,584,000
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Boxes 24 and 27: Following the entering into of the Supplemental Agreement to the 2017 Concert Party Agreement between Mr. Xiong Jun and the parties acting in concert with him on 11 April 2025, the number of shares in which Tang Yi's controlled corporations, being parties to the 2017 Concert Party Agreement, are interested has reduced. For details, please refer to the announcement of the Company dated 11 April 2025.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 16/04/2025
(dd/mm/yyyy)